本页面由Tiger Trade Technology Pte. Ltd.提供服务

Precision Biosciences Inc

4.17
-0.0350-0.83%
成交量:5.76万
成交额:23.68万
市值:1.00亿
市盈率:-0.50
高:4.20
开:4.05
低:4.01
收:4.20
52周最高:8.82
52周最低:3.53
股本:2,407.18万
流通股本:2,282.25万
量比:0.60
换手率:0.25%
股息:- -
股息率:- -
每股收益(TTM):-8.3225
每股收益(LYR):1.04
净资产收益率:-205.16%
总资产收益率:-45.34%
市净率:6.03
市盈率(LYR):4.00

数据加载中...

2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2025/12/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/12

重要事件披露

Form 8-K - Current report
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/09/02

重要事件披露

Form 8-K - Current report